Cargando…
Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections
The repositioning of drugs already approved by regulatory agencies for other indications is an emerging alternative for the development of new antimicrobial therapies. The repositioning process involves lower risks and costs than the de novo development of novel antimicrobial drugs. Currently, infec...
Autores principales: | Marrugal-Lorenzo, José A., Serna-Gallego, Ana, Berastegui-Cabrera, Judith, Pachón, Jerónimo, Sánchez-Céspedes, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327057/ https://www.ncbi.nlm.nih.gov/pubmed/30626902 http://dx.doi.org/10.1038/s41598-018-37290-3 |
Ejemplares similares
-
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2015) -
Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome
por: Xu, Jimin, et al.
Publicado: (2021) -
T-cell immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients
por: Sánchez-Céspedes, Javier, et al.
Publicado: (2020) -
Salicylanilides and Their Anticancer Properties
por: Kauerová, Tereza, et al.
Publicado: (2023) -
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
por: Nygren, Peter, et al.
Publicado: (2013)